Digital tool for monitoring chronic myeloid leukemia patients
Part of Cancer clinical trials.
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. It may help ensure you stay well after stopping treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have chronic myeloid leukemia and have not taken treatment for 2 years or less
- You have a device (like a smartphone, tablet, or computer) with internet access
- You are enrolled in the French social security system
- You understand French and can read the study information
- You are not in a situation where you need special protection (like being a minor, in custody, or living in a care facility)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how digital tools (apps or websites) can help people affected by cancer, including patients, caregivers, and healthcare workers. If you are a current or past cancer patient, a caregiver, or an oncology professional, you may be able to join.
This trial is testing if a special electronic device can help you remember to take your oral medications for blood disorders. It's for people who need to take pills for at least 6 months and who have internet access.
This trial tests if using a connected scale to monitor your weight at home can help your doctors manage your treatment for aggressive non-Hodgkin's lymphoma or multiple myeloma. It may also apply if you need a stem cell transplant (autograft) for these conditions.
This study tests a digital way for older adults with acute leukemia to report their symptoms and quality of life from home. Instead of only talking to your doctor at appointments, you might use an app or a website to answer questionnaires, which could help your care team notice issues earlier and adjust your care.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
This study tests a digital application to help patients with acute myeloid leukemia (AML) during their hospital stay. It may assist with tracking symptoms, education, or communication with care teams.
Hear when a new Chronic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.